Packaging for Semaglutide 2.4 mg
Novo Nordisk A/S
The packaging material for Semaglutide 2.4 mg, including the carton box and partition board.
This certificate covers the following products:
Included: Secondary paperboard packaging including carton and partition board. Excluded: Leaflets and pen-injector.
This product has been certified according to the Version 4.0 Draft 1 requirements for General Requirements, Material Health, Clean Air & Climate Protection, and Social Fairness. It has been certified according to the Version 4.0 Draft 2 requirements for Product Circularity and Water & Soil Stewardship.
As a result of travel restrictions due to COVID 19, no site visit could be conducted. This certificate has been issued on a provisional basis.
Sourcing information: The two final manufacturing facilities and all tier 1 suppliers to final manufacturing are located in the United States.